96 related articles for article (PubMed ID: 22888118)
1. Structural flexibility regulates phosphopeptide-binding activity of the tyrosine kinase binding domain of Cbl-c.
Takeshita K; Tezuka T; Isozaki Y; Yamashita E; Suzuki M; Kim M; Yamanashi Y; Yamamoto T; Nakagawa A
J Biochem; 2012 Nov; 152(5):487-95. PubMed ID: 22888118
[TBL] [Abstract][Full Text] [Related]
2. Structural analysis of the TKB domain of ubiquitin ligase Cbl-b complexed with its small inhibitory peptide, Cblin.
Ohno A; Ochi A; Maita N; Ueji T; Bando A; Nakao R; Hirasaka K; Abe T; Teshima-Kondo S; Nemoto H; Okumura Y; Higashibata A; Yano S; Tochio H; Nikawa T
Arch Biochem Biophys; 2016 Mar; 594():1-7. PubMed ID: 26874193
[TBL] [Abstract][Full Text] [Related]
3. A mouse with a loss-of-function mutation in the c-Cbl TKB domain shows perturbed thymocyte signaling without enhancing the activity of the ZAP-70 tyrosine kinase.
Thien CB; Scaife RM; Papadimitriou JM; Murphy MA; Bowtell DD; Langdon WY
J Exp Med; 2003 Feb; 197(4):503-13. PubMed ID: 12591907
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for a novel intrapeptidyl H-bond and reverse binding of c-Cbl-TKB domain substrates.
Ng C; Jackson RA; Buschdorf JP; Sun Q; Guy GR; Sivaraman J
EMBO J; 2008 Mar; 27(5):804-16. PubMed ID: 18273061
[TBL] [Abstract][Full Text] [Related]
5. Additional serine/threonine phosphorylation reduces binding affinity but preserves interface topography of substrate proteins to the c-Cbl TKB domain.
Sun Q; Jackson RA; Ng C; Guy GR; Sivaraman J
PLoS One; 2010 Sep; 5(9):e12819. PubMed ID: 20877636
[TBL] [Abstract][Full Text] [Related]
6. High-throughput fluorescence polarization assay to identify inhibitors of Cbl(TKB)-protein tyrosine kinase interactions.
Kumar EA; Charvet CD; Lokesh GL; Natarajan A
Anal Biochem; 2011 Apr; 411(2):254-60. PubMed ID: 21129358
[TBL] [Abstract][Full Text] [Related]
7. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.
Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M
J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609
[TBL] [Abstract][Full Text] [Related]
8. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase.
Meng W; Sawasdikosol S; Burakoff SJ; Eck MJ
Nature; 1999 Mar; 398(6722):84-90. PubMed ID: 10078535
[TBL] [Abstract][Full Text] [Related]
9. Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation.
Masson K; Heiss E; Band H; Rönnstrand L
Biochem J; 2006 Oct; 399(1):59-67. PubMed ID: 16780420
[TBL] [Abstract][Full Text] [Related]
10. Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene.
Nadeau SA; An W; Mohapatra BC; Mushtaq I; Bielecki TA; Luan H; Zutshi N; Ahmad G; Storck MD; Sanada M; Ogawa S; Band V; Band H
J Biol Chem; 2017 Mar; 292(9):3666-3682. PubMed ID: 28082680
[TBL] [Abstract][Full Text] [Related]
11. Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins.
Hu J; Hubbard SR
J Biol Chem; 2005 May; 280(19):18943-9. PubMed ID: 15737992
[TBL] [Abstract][Full Text] [Related]
12. The multidomain protooncogenic protein c-Cbl binds to tubulin and stabilizes microtubules.
Teckchandani AM; Birukova AA; Tar K; Verin AD; Tsygankov AY
Exp Cell Res; 2005 May; 306(1):114-27. PubMed ID: 15878338
[TBL] [Abstract][Full Text] [Related]
13. SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function.
Wybenga-Groot LE; Tench AJ; Simpson CD; Germain JS; Raught B; Moran MF; McGlade CJ
J Mol Biol; 2021 Apr; 433(8):166880. PubMed ID: 33617900
[TBL] [Abstract][Full Text] [Related]
14. c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses.
Thien CB; Langdon WY
Biochem J; 2005 Oct; 391(Pt 2):153-66. PubMed ID: 16212556
[TBL] [Abstract][Full Text] [Related]
15. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein.
Peschard P; Fournier TM; Lamorte L; Naujokas MA; Band H; Langdon WY; Park M
Mol Cell; 2001 Nov; 8(5):995-1004. PubMed ID: 11741535
[TBL] [Abstract][Full Text] [Related]
16. Identification and functional characterization of an Src homology domain 3 domain-binding site on Cbl.
Sanjay A; Miyazaki T; Itzstein C; Purev E; Horne WC; Baron R
FEBS J; 2006 Dec; 273(23):5442-56. PubMed ID: 17094785
[TBL] [Abstract][Full Text] [Related]
17. An adjacent arginine, and the phosphorylated tyrosine in the c-Met receptor target sequence, dictates the orientation of c-Cbl binding.
Sun Q; Ng C; Guy GR; Sivaraman J
FEBS Lett; 2011 Jan; 585(2):281-5. PubMed ID: 21163258
[TBL] [Abstract][Full Text] [Related]
18. C-Cbl binds the CSF-1 receptor at tyrosine 973, a novel phosphorylation site in the receptor's carboxy-terminus.
Wilhelmsen K; Burkhalter S; van der Geer P
Oncogene; 2002 Feb; 21(7):1079-89. PubMed ID: 11850825
[TBL] [Abstract][Full Text] [Related]
19. A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis.
Singh AJ; Meyer RD; Navruzbekov G; Shelke R; Duan L; Band H; Leeman SE; Rahimi N
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5413-8. PubMed ID: 17372230
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b.
Peschard P; Kozlov G; Lin T; Mirza IA; Berghuis AM; Lipkowitz S; Park M; Gehring K
Mol Cell; 2007 Aug; 27(3):474-85. PubMed ID: 17679095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
